Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Norovirus Bivalent-Vaccine Efficacy Study: Complete Statistical AnalysisIndependent statistical analysis of Norovirus Bivalent-Vaccine Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01609257).
- NOSE-400Independent statistical analysis of A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NOTABLeIndependent statistical analysis of Neuromodulation for Accidental Bowel Leakage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03278613).
- NOTESIndependent statistical analysis of Natural Orifice Transgastric Endoscopic (NOTES) Transgastric Diagnostic Peritoneoscopy With Laparoscopic Assistance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NOTOXISIndependent statistical analysis of SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NOURISHIndependent statistical analysis of NOURISH: Nourishing Our Understanding of Role Modeling to Improve Support and Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NOVA2Independent statistical analysis of Inhaled Nitric Oxide and Neuroprotection in Premature Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00515281).
- Novartis H1N1 Vaccine in Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Novartis H1N1 Vaccine in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00992719).
- Novel Airway Device to Aid Endotracheal Intubations: Complete Statistical AnalysisIndependent statistical analysis of Novel Airway Device to Aid Endotracheal Intubations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03340207).
- Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE): Complete Statistical AnalysisIndependent statistical analysis of Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04447846).
- Novel Helmet Design in Patients With Seizures: Complete Statistical AnalysisIndependent statistical analysis of Novel Helmet Design in Patients With Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03443388).
- Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action: Complete Statistical AnalysisIndependent statistical analysis of Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04271202).
- Novel Management of Airway Protection in Parkinson’s Disease: A Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study: Complete Statistical AnalysisIndependent statistical analysis of Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05371509).
- Novel Optical Surface Image Guidance System for Beam-Gated Online Adaptive SBRT Delivery in Mobile Lower Lung and Upper Abdominal Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Novel Optical Surface Image Guidance System for Beam-Gated Online Adaptive SBRT Delivery in Mobile Lower Lung and Upper Abdominal Malignancies: primary endpoint results, effect estimate with confidence interval,…
- Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer: primary endpoint results, effect estimate with…
- Novel Pharyngeal Metrics to Predict Dysphagia Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Novel Pharyngeal Metrics to Predict Dysphagia Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04569097).
- Novel Portable Diagnostic Device for Automatic Detection of Relative Afferent Pupillary Defect: Complete Statistical AnalysisIndependent statistical analysis of Novel Portable Diagnostic Device for Automatic Detection of Relative Afferent Pupillary Defect: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Novel Treatment of Comorbid Insomnia and Sleep Apnea in Older Veterans: Complete Statistical AnalysisIndependent statistical analysis of Novel Treatment of Comorbid Insomnia and Sleep Apnea in Older Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Novel Use of an Enhanced Fluoroscopic Imaging Device to Reduce Radiation Exposure and Operative Time During Intramedullary Nailing of Hip Fractures: Complete Statistical AnalysisIndependent statistical analysis of Novel Use of an Enhanced Fluoroscopic Imaging Device to Reduce Radiation Exposure and Operative Time During Intramedullary Nailing of Hip Fractures: primary endpoint results, effect estimate with confidence…
- NOVELAIndependent statistical analysis of Improving Self-Efficacy Through a Telenovela: Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04533594).
- NOVEMBERIndependent statistical analysis of Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NOVESAIndependent statistical analysis of A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- NOWDx Test for the Detection of Antibodies to COVID-19: Complete Statistical AnalysisIndependent statistical analysis of NOWDx Test for the Detection of Antibodies to COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04690413).
- nPower™-USIndependent statistical analysis of Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies: Complete Statistical AnalysisIndependent statistical analysis of NPWT in Patients Undergoing Surgical Procedures for Management of GI Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NPWTCSIndependent statistical analysis of Negative Pressure Wound Therapy in Cesarean Section: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02289157).
- NR in Chemo-induced Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of NR in Chemo-induced Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03642990).
- NRRIndependent statistical analysis of Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NRRIndependent statistical analysis of Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- NRRIndependent statistical analysis of Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NSAID Effects on Clinical and Imaging Breast Biomarkers: Complete Statistical AnalysisIndependent statistical analysis of NSAID Effects on Clinical and Imaging Breast Biomarkers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01761877).
- NSAID Use in Postpartum Hypertensive Women: Complete Statistical AnalysisIndependent statistical analysis of NSAID Use in Postpartum Hypertensive Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02902172).
- NSCLCIndependent statistical analysis of Multicenter Study of Rociletinib Administered to Patients With Previously Treated Mutant EGFR Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- NSCLCIndependent statistical analysis of Study of Bevacizumab and Erlotinib in Patients With Advanced Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NSCLCIndependent statistical analysis of Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00673049).
- NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries: Complete Statistical AnalysisIndependent statistical analysis of NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- nSTRIDE APS Versus Hyaluronic Acid for Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of nSTRIDE APS Versus Hyaluronic Acid for Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03182374).
- NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- NT-I7 for Kaposi Sarcoma in Patients With or Without HIV: Complete Statistical AnalysisIndependent statistical analysis of NT-I7 for Kaposi Sarcoma in Patients With or Without HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04893018).
- NTRKIndependent statistical analysis of A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NTXIndependent statistical analysis of Naltrexone for Antipsychotic-Induced Weight Gain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01866098).
- NTXIndependent statistical analysis of Stryker NTX Registry Scorpio NRG (Re-"Energize"), Triathlon Total Knee, Triathlon Partial Knee Resurfacing (PKR) With X3 Polyethylene Insert: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- NTX-PED-001Independent statistical analysis of Efficacy and Safety Study of Nexagon for Persistent Corneal Epithelial Defects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer: Complete Statistical AnalysisIndependent statistical analysis of Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05276401).
- NU-DSMPIndependent statistical analysis of Pilot Trial of the Nutrition-Supported Diabetes Education Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05067452).
- NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours: Complete Statistical AnalysisIndependent statistical analysis of NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- NUCALA® Special Drug Use Investigation (EGPA, Long-term): Complete Statistical AnalysisIndependent statistical analysis of NUCALA® Special Drug Use Investigation (EGPA, Long-term): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03557060).